These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19264821)

  • 1. Tight control of blood glucose in long standing type 2 diabetes.
    Lehman R; Krumholz HM
    BMJ; 2009 Mar; 338():b800. PubMed ID: 19264821
    [No Abstract]   [Full Text] [Related]  

  • 2. Is tight glycemic control in type 2 diabetes really worthwhile? Yes.
    Clement M; Bhattacharyya O; Conway JR
    Can Fam Physician; 2009 Jun; 55(6):580, 582, 584, 586, 588. PubMed ID: 19509194
    [No Abstract]   [Full Text] [Related]  

  • 3. [Diabetic patients with heart disease. Especially strict blood values are important here].
    Standl E
    MMW Fortschr Med; 2006 Oct; 148(41):11. PubMed ID: 17190249
    [No Abstract]   [Full Text] [Related]  

  • 4. Safety of very tight glucose control in type 2 diabetes in question.
    Idris I
    Diabetes Obes Metab; 2008 May; 10(5):438. PubMed ID: 18431839
    [No Abstract]   [Full Text] [Related]  

  • 5. Summaries for patients. Control of blood sugar in type 2 diabetes: a guidance statement from the American College of Physicians.
    Ann Intern Med; 2007 Sep; 147(6):I52. PubMed ID: 17876018
    [No Abstract]   [Full Text] [Related]  

  • 6. Importance of glycemic control.
    Shahady EJ
    J Fam Pract; 2011 Sep; 60(9 Suppl):S4-6. PubMed ID: 21912776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Preventing infarct in the diabetic patient. Lowering blood glucose and HbA1c are not enough].
    Reblin T; Seidel D; Stein D; Görtz A; Lander T
    MMW Fortschr Med; 2003 May; 145(19):41. PubMed ID: 12813977
    [No Abstract]   [Full Text] [Related]  

  • 8. Guideline adaptation: an appealing alternative to de novo guideline development.
    Palda VA; Graham ID; Davis D; Burgers J; Brouwers M; Cluzeau F;
    Ann Intern Med; 2008 Apr; 148(7):564; author reply 564-5. PubMed ID: 18378957
    [No Abstract]   [Full Text] [Related]  

  • 9. Guideline adaptation: an appealing alternative to de novo guideline development.
    Fervers B; Remy-Stockinger M; Graham ID; Burnand B; Harrison M; Browman G; Latreille J
    Ann Intern Med; 2008 Apr; 148(7):563-4; author reply 564-5. PubMed ID: 18378955
    [No Abstract]   [Full Text] [Related]  

  • 10. Cardiovascular disease (CVD) limbo: how soon and low should we go to prevent CVD in diabetes?
    Maahs DM
    Diabetes Technol Ther; 2012 Jun; 14(6):449-52. PubMed ID: 22472062
    [No Abstract]   [Full Text] [Related]  

  • 11. Can the atherosclerosis prevention targets be achieved in type 2 diabetes?
    Skrha J; Ambos A
    Diabetes Res Clin Pract; 2005 Jun; 68 Suppl1():S48-51. PubMed ID: 15955375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How low to go? Blood glucose and heart health.
    Diabetes Forecast; 2008 Apr; 61(4):21. PubMed ID: 18478637
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intensive blood sugar treatment in type 2 diabetics: no evidence for increased mortality in the ADVANCE study compared with ACCORD study].
    Füchtenbusch M; Hummel M
    MMW Fortschr Med; 2008 Apr; 150(17):42-4. PubMed ID: 18510157
    [No Abstract]   [Full Text] [Related]  

  • 14. Case study 1: exploring the pharmacologic agents for treatment of type 2 diabetes.
    Martin CL
    Diabetes Educ; 2007; 33 Suppl 1():6S-13S. PubMed ID: 17272803
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes mellitus and cardiovascular risk factors: more insights revisited.
    Rangan S; Singh PK; Tahrani AA; Varughese GI
    Int J Clin Pract; 2007 Jun; 61(6):1055-6. PubMed ID: 17504368
    [No Abstract]   [Full Text] [Related]  

  • 16. [Intensive therapy in type 2 diabetes. More damage than benefit?].
    Einecke D
    MMW Fortschr Med; 2008 Jun; 150(26-27):12-4. PubMed ID: 18681224
    [No Abstract]   [Full Text] [Related]  

  • 17. Blood glucose control and microvascular complications--what do we do now?
    Dahl-Jørgensen K; Brinchmann-Hansen O; Bangstad HJ; Hanssen KF
    Diabetologia; 1994 Dec; 37(12):1172-7. PubMed ID: 7895945
    [No Abstract]   [Full Text] [Related]  

  • 18. Type 2 diabetes and HbA1c goal: time for individualised therapy.
    Jabbour S
    Int J Clin Pract; 2009 Oct; 63(10):1408-9. PubMed ID: 19769696
    [No Abstract]   [Full Text] [Related]  

  • 19. Optimizing diabetes management through glucose profiling: a case-based approach.
    Streja DA
    Prim Care Diabetes; 2008 Dec; 2(4):167-73. PubMed ID: 18786873
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glycemic Variability and Diabetes Complications: Does It Matter? Of Course It Does!
    Hirsch IB
    Diabetes Care; 2015 Aug; 38(8):1610-4. PubMed ID: 26207054
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.